FrancophonIA/ELRC3.0 huggingface dataset:
English: Contact your doctor as soon as possible if you: - have an unexplained skin rash, as this could develop into a more severe skin rash or skin peeling - feel unusually tired or feverish, have a sore throat, swollen glands, or find that you bruise more easily, as this may mean you have a blood disorder - have signs of increased acid level in the blood- headaches, drowsiness, shortness of breath and loss of appetite.
Croatian: Obratite se liječniku čim prije ako: - imate neobjašnjiv osip na koži, jer se to može razviti u teži osip ili ljuštenje kože - osjećate se neobično umorno ili kao da imate temperaturu, boli Vas grlo, imate otečene žlijezde ili Vam se češće stvaraju modrice, jer to može značiti da imate poremećaj krvi - opazite znakove povećane razine kiseline u krvi - glavobolje, osjećate omamljenost, nedostatak zraka i gubitak apetita.
English: Potential medicinal product interactions affecting zonisamide In clinical studies co-administration of lamotrigine had no apparent effect on zonisamide pharmacokinetics.
Croatian: U kliničkim ispitivanjim istodobna primjena lamotrigina nije imala vidljiv učinak na farmakokinetiku zonisamida.
English: Respiratory disorder
Croatian: Oštećenje jetre
English: What Zonisamide Mylan is and what it is used for Zonisamide Mylan contains the active substance zonisamide, and is used as an antiepileptic medicine.
Croatian: Zonisamide Mylan sadrži djelatnu tvar zonisamid i koristi se kao lijek protiv epilepsije.
English: Week 1 + 2 Week 3 + 4 Week 5 + 6
Croatian: + 2. tjedan 3. + 4. tjedan 5. + 6. tjedan 100 mg na dan (jedanput na dan)
English: Zonisamide should be used with caution in adult patients treated concomitantly with carbonic anhydrase inhibitors such as topiramate and acetazolamide, as there are insufficient data to rule out a possible pharmacodynamic interaction (see section 4.4).
Croatian: Zonisamid treba primjenjivati oprezno u odraslih bolesnika istodobno liječenih inhibitorima karboanhidraze kao što su topiramat i acetazolamid, jer nema dovoljno podataka koji bi isključili moguću farmakodinamičku interakciju (vidjeti dio 4.4).
English: Zonisamide Mylan may be used:
Croatian: Zonisamide Mylan se može primjenjivati:
English: Nephrolithiasis may lead to chronic kidney damage.
Croatian: Neftrolitijaza može dovesti do kroničnog oštećenja bubrega.
English: Uncommon (may affect up to 1 in 100 people): - anger, aggression, thoughts of suicide, suicide attempt - gall bladder inflammation, gallstones - urinary stones - lung infection / inflammation, urinary tract infections - low blood potassium levels, convulsions/seizures - breathing disorders - hallucinations - abnormal urine tests.
Croatian: Manje česte nuspojave (mogu se javiti u do 1 na 100 osoba): - ljutnja, agresija, misli o samoubojstvu, pokušaj samoubojstva - upala žučnog mjehura, žučni kamenci - mokraćni kamenci - infekcija pluća / upala, infekcije mokraćnog sustava - niske razine kalija u krvi, konvulzije / napadaji - poremećaji disanja - halucinacije - poremećeni nalazi mokraće.
English: Anhidrosis Erythema multiforme Stevens-Johnson syndrome
Croatian: Stevens-Johnsonov sindrom, toksična epidermalna nekroliza
English: If you are younger than 6 years old, Zonisamide Mylan is not recommended for you - are elderly, as your dose of Zonisamide Mylan may need adjusting, and you may be more likely to develop an allergic reaction, severe skin rash, swelling of the feet and legs, and itchiness when taking Zonisamide Mylan (see section 4 Possible Side Effects) - suffer from liver problems, as your dose of Zonisamide Mylan may need adjusting - have eye problems such as glaucoma - suffer from kidney problems as your dose of Zonisamide Mylan may need adjusting - have previously suffered from kidney stones, as you may be at increased risk of developing more kidney stones.
Croatian: Obratite se svom liječniku ili ljekarniku prije nego uzmete Zonisamide Mylan ako ste: - mlađi od 12 godina jer je možda za Vas veći rizik od smanjenog znojenja, toplinskog udara, upale pluća i tegoba s jetrom; ako ste mlađi od 6 godina, Zonisamide Mylan se za Vas ne preporučuje - starije dobi, jer Vašu dozu lijeka Zonisamide Mylan možda treba prilagoditi i za Vas je veća vjerojatnost pojave alergijske reakcije, teškog osipa na koži, oticanja stopala i nogu te svrbeža kada uzimate Zonisamide Mylan (vidjeti dio 4. Moguće nuspojave) - patite od tegoba s jetrom jer Vam možda treba prilagoditi dozu lijeka Zonisamide Mylan - imate tegobe s očima poput glaukoma - patite od tegoba s bubrezima jer Vam možda treba prilagoditi dozu lijeka Zonisamide Mylan - ako ste prethodno patili od bubrežnih kamenaca, jer u Vas možda postoji rizik da ćete razviti još više bubrežnih kamenaca.
English: Method of administration Zonisamide Mylan hard capsules are for oral use.
Croatian: Način primjene Zonisamide Mylan tvrde kapsule primjenjuju se peroralno.
English: Zonisamide Mylan belongs to a group of medicines (sulfonamides) that can cause severe allergic reactions, severe skin rashes, and blood disorders, which very rarely can be fatal.
Croatian: Zonisamide Mylan pripada skupini lijekova (sulfonamida) koji mogu uzrokovati teške alergijske reakcije, teške osipe na koži i poremećaje krvi, vrlo rijetko sa smrtnim ishodom.
English: The warnings and precautions mentioned below are more relevant to paediatric and adolescent patients.
Croatian: Upozorenja i mjere opreza koje slijede odnose se u većoj mjeri na pedijatrijske i adolescentne bolesnike.
English: Paediatric population (aged 6 years and above) - recommended down-titration schedule Weight
Croatian: Tablica 3. Pedijatrijska populacija (u dobi od 6 i više godina) - preporučeni režim postupnog smanjivanja doze
English: In subjects with renal impairment, renal clearance of single doses of zonisamide was positively correlated with creatinine clearance.
Croatian: U bolesnika s oštećenjem bubrega, bubrežni klirens jednokratnih doza zonisamida pozitivno je korelirao s klirensom kreatinina.
English: 50 mg/day (in two divided doses)
Croatian: 50 mg na dan (podijeljeno u dvije doze)
English: Serious immune based adverse reactions that are associated with medicinal products containing a sulfonamide group include rash, allergic reaction and major haematological disturbances including aplastic anaemia, which very rarely can be fatal (see section 4.4).
Croatian: Ozbiljne nuspojave imunološke naravi povezane s lijekovima koji sadrže sulfonamidnu skupinu uključuju osip, alergijsku reakciju i velike hematološke poremećaje, uključujući aplastičnu anemiju koja vrlo rijetko može imati smrtni ishod (vidjeti dio 4.4).
English: How to store Zonisamide Mylan
Croatian: Kako čuvati Zonisamide Mylan
English: Drug-induced hypersensitivity syndrome Drug rash with eosinophilia and systemic symptoms
Croatian: Poremećaji imunološkog sustava preosjetljivost sindrom preosjetljivosti izazvan lijekom, medikamentozni osip s eozinofilijom i sistemskim simptomima
English: Increase at twoweekly intervals in increments of 1 mg/kg
Croatian: Povećavati u razmacima od dva tjedna s povećanjem doze za 1 mg/kg
English: Serious immune based adverse reactions that are associated with medicinal products containing a sulfonamide group include rash, allergic reaction and major haematological disturbances, including aplastic anaemia, which very rarely can be fatal.
Croatian: Ozbiljne nuspojave imunološke naravi povezane s lijekovima koji sadrže sulfonamidnu skupinu uključuju osip, alergijsku reakciju i velike hematološke poremećaje, uključujući aplastičnu anemiju koja vrlo rijetko može imati smrtni ishod.
English: 100 mg/day (in two divided doses)
Croatian: 100 mg na dan (podijeljeno u dvije doze)
English: 1 mg/kg/day (once a day)
Croatian: 1 mg/kg na dan (jedanput na dan)
English: Zonisamide should be used with caution in adult patients being treated concomitantly with carbonic anhydrase inhibitors such as topiramate or acetazolamide, as there are insufficient data to rule out a pharmacodynamic interaction (see also section 4.4 Paediatric Population and section 4.5).
Croatian: Zonisamid treba primjenjivati oprezno u odraslih bolesnika koji se istodobno liječe inhibitorima karboanhidraze, kao što je topiramat ili acetazolamid, jer nema dovoljno podataka koji bi isključili farmakodinamičku interakciju (vidjeti također dio 4.4, Pedijatrijska populacija i dio 4.5).
English: Eye disorders
Croatian: Poremećaji oka diplopija
English: Blood and lymphatic system disorders
Croatian: Poremećaji krvi i limfnog sustava leukopenija, trombocitopenija
English: Zonisamide Mylan belongs to a group of medicines (sulfonamides) which can cause severe allergic reactions, severe skin rashes, and blood disorders, which very rarely can be fatal (see section 4.
Croatian: Zonisamide Mylan pripada skupini lijekova (sulfonamida) koji mogu uzrokovati teške alergijske reakcije, teške osipe na koži i poremećaje krvi, vrlo rijetko sa smrtnim ishodom (vidjeti dio 4, Moguće nuspojave).
English: PVC-PVdC/Aluminium foil blisters in cardboard cartons containing 14, 28 and 56 capsules.
Croatian: PVC-PVdC/ blisteri s aluminijskom folijom u kartonskim kutijama koje sadrže 14, 28 i 56 kapsula.
English: PVC-PVdC/Aluminium foil perforated unit dose blisters in cardboard cartons containing 14 x 1 capsules.
Croatian: PVC-PVdC/ perforirani blisteri s aluminijskom folijom djeljivi na jedinične doze u kartonskim kutijama koje sadrže 14 × 1 kapsulu.
English: Status epilepticus
Croatian: Antiepileptički lijekovi
English: P-gp substrate
Croatian: Supstrat P-glikoproteina
English: Hepatic dysfunction
Croatian: Disfunkcija jetre
English: Increase at weekly intervals in increments of 1 mg/kg
Croatian: Povećavati u razmacima od tjedan dana s povećanjem doze za 1 mg/kg
English: Increase at twoweekly intervals in increments of up to 100 mg
Croatian: povećavati u razmacima od dva tjedna s povećanjem doze do 100 mg
English: Kidney stones have occurred in paediatric patients (see section 4.4 Kidney stones for full warning).
Croatian: Nastanak bubrežnih kamenaca zabilježen je u pedijatrijskoj populaciji (za sva upozorenja vidjeti dio 4.4, Bubrežni kamenci).
English: A dietary supplement or increased food intake should be considered if the patient is failing to gain weight in accordance with growth charts, otherwise zonisamide should be discontinued.
Croatian: Ako bolesnik ne uspijeva dobivati na težini u skladu s prosjekom rasta, može se razmotriti upotreba dodataka prehrani ili povećanje unosa hrane; u protivnom liječenje zonisamidom treba prekinuti.
English: Renal ultrasound should be performed at the discretion of the physician.
Croatian: Prema prosudbi liječnika treba provoditi ultrazvučne preglede bubrega.
English: Iron oxide Red (E172)
Croatian: Tinta za označavanje šelak crveni željezov oksid (E172) 6.2 Inkompatibilnosti
English: Adverse reactions in a randomised, controlled monotherapy trial comparing zonisamide with carbamazepine prolonged release System Organ Class (MedDRA terminology†)
Croatian: Tablica 5. Nuspojave iz randomiziranog, kontroliranog ispitivanja monoterapije zonisamidom u usporedbi s monoterapijom karbamazepinom produljenog otpuštanja
English: A dietary supplement or increased food intake may be considered if the patient is losing weight or is underweight whilst on this medication.
Croatian: Ako bolesnik za vrijeme uzimanja ovog lijeka gubi na težini ili je njegova težina manja od prosječne, može se razmotriti upotreba dodataka prehrani ili povećanje unosa hrane.
English: Hypokalaemia Metabolic acidosis Renal tubular acidosis
Croatian: Poremećaji metabolizma i prehrane anoreksija hipokalemija metabolička acidoza, bubrežna tubularna acidoza
English: Zonisamide Mylan must be added to existing therapy for paediatric patients aged 6 years and above.
Croatian: Pedijatrijskim bolesnicima u dobi od 6 i više godina, Zonisamide Mylan se mora dodati već postojećoj terapiji.
English: Zonisamide Mylan 100 mg hard capsules have a white body and white cap, marked ‘Z 100' in black and contain a white/almost white powder.
Croatian: Zonisamide Mylan 100 mg tvrde kapsule imaju bijelo tijelo i bijelu kapicu s crnom oznakom „Z 100” i sadrže bijeli/gotovo bijeli prašak.
English: PVC-PVdC/Aluminium foil perforated unit dose blisters in cardboard cartons containing 56 x 1 capsules.
Croatian: PVC-PVdC/ perforirani blisteri s aluminijskom folijom djeljivi na jedinične doze u kartonskim kutijama koje sadrže 56 × 1 kapsulu.
English: Zonisamide should not be used as co-medication in paediatric patients with other carbonic anhydrase inhibitors such as topiramate and acetazolamide (see section 4.5).
Croatian: U pedijatrijskih bolesnika zonisamid se ne smije primjenjivati s drugim inhibitorima karboanhidraze kao što su topiramat i acetazolamid (vidjeti dio 4.5).
English: Common (may affect up to 1 in 10 people): - difficulty sleeping, strange or unusual thoughts, feeling anxious or emotional - slowed thoughts, loss of concentration, speech abnormalities, abnormal skin sensation (pins and needles), tremor, involuntary movement of the eyes - kidney stones - skin rashes, itching, allergic reactions, fever, tiredness, flu-like symptoms, hair loss - ecchymosis (a small bruise caused by blood leaking from broken blood vessels in the skin) - loss of weight, nausea, indigestion, stomach pains, diarrhoea (loose stools), constipation - swelling of the feet and legs - vomiting - mood swings - increased blood levels of creatinine (a waste product that your kidneys should normally remove) - increased levels of liver enzymes in the blood.
Croatian: drhtanje, nevoljni pokreti očiju - bubrežni kamenci - osipi po koži, svrbež, alergijske reakcije, vrućica, umor, simptomi nalik gripi, gubitak kose - ekhimoza (mala modrica koju uzrokuje istjecanje krvi iz oštećenih krvnih žila u koži) - gubitak težine, mučnina, probavne tegobe, bolovi u želucu, proljev, zatvor - oticanje stopala i nogu - povraćanje - promjene raspoloženja - povećane razine kreatinina u krvi (otpadni produkt koji bi u normalnim okolnostima Vaši bubrezi trebali ukloniti) - povećana razina jetrenih enzima u krvi.
English: Increase at weekly intervals in increments of 100 mg
Croatian: povećavati u razmacima od tjedan dana s povećanjem doze za 100 mg
English: Do not reduce your dose or stop your medicine unless your doctor tells you to. - If your doctor advises you to stop taking Zonisamide Mylan your dose will be reduced gradually to lower the risk of more seizures.
Croatian: - Ako Vam liječnik savjetuje da prestanete uzimati Zonisamide Mylan, Vaša će se doza postupno smanjivati kako bi se smanjio rizik od dodatnih napadaja.
English: Zonisamide should not be used as co-medication in paediatric patients with other carbonic anhydrase inhibitors such as topiramate and acetazolamide (see section 4.4: Paediatric population).
Croatian: Zonisamid se u pedijatrijskih bolesnika ne smije primjenjivati istodobno s drugim inhibitorima karboanhidraze kao što su topiramat i acetazolamid (vidjeti dio 4.4, Pedijatrijska populacija).
English: What Zonisamide Mylan contains:
Croatian: Sadržaj pakiranja i druge informacije Što Zonisamide Mylan sadrži:
English: Pneumonia aspiration Respiratory disorder Hypersensitivity-type Pneumonitis
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja dispneja, aspiracijska pneumonija, poremećaj disanja, hipersenzitivni pneumonitis
English: Adverse reactions associated with zonisamide obtained from adjunctive use clinical studies and post-marketing surveillance System Organ
Croatian: Tablica 4. Nuspojave povezane sa zonisamidom iz kliničkih ispitivanja dodatne primjene i praćenja nakon stavljanja lijeka u promet
English: Zonisamide Mylan 25 mg hard capsules have a white body and a white cap, marked ‘Z 25' in black and contain a white/almost white powder.
Croatian: Zonisamide Mylan 25 mg tvrde kapsule imaju bijelo tijelo i bijelu kapicu s crnom oznakom „Z 25” i sadrže bijeli/gotovo bijeli prašak.
English: Skin and subcutaneous tissue disorders
Croatian: Poremećaji kože i potkožnog tkiva osip pruritus, ekhimoza
English: Zonisamide Mylan 50 mg hard capsules have a white body and white cap, marked ‘Z 50' in red and contain a white/almost white powder.
Croatian: Zonisamide Mylan 50 mg tvrde kapsule imaju bijelo tijelo i bijelu kapicu s crvenom oznakom „Z 50” i sadrže bijeli/gotovo bijeli prašak.
English: - shortness of breath, inflammation of the lungs - inflammations of the pancreas (severe pain in the stomach or back) - liver problems, kidney failure - severe rashes or skin peeling (at the same time you may feel unwell or develop a fever) - abnormal muscle breakdown (you may feel pain or weakness in your muscles) which can lead to kidney problems - swollen glands, blood disorders (reduction in the number of blood cells, which can make infection more likely and can make you look pale, feel tired and feverish, and bruise more easily) - decreased sweating, overheating - problems with your urine - increased blood levels of creatine phosphokinase or urea which can be seen in a blood test - abnormal results from liver function tests - glaucoma, which is a blockage of fluid in the eye causing increased pressure in the eye.
Croatian: vrućica, nemogućnost zadržavanja mokraće), epileptički status (produljeni ili ponavljani napadaji) - nedostatak zraka, upala pluća - upala gušterače (teška bol u trbuhu ili leđima) - tegobe s jetrom, zatajenje bubrega - teški osipi ili ljuštenje kože (a istodobno se možete osjećati loše ili razviti vrućicu) - nenormalno propadanje mišića (možete osjećati bol ili slabost u mišićima) koje može dovesti do tegoba s bubrezima - otečene žlijezde, poremećaji krvi (smanjeni broj krvnih stanica zbog čega se može povećati mogućnost nastanka infekcije i možete biti blijedi, osjećati se umorno i kao da imate vrućicu,
English: Therefore children aged 6 years and above with a body weight of less than 20 kg should be treated with caution.
Croatian: Stoga je potreban oprez pri liječenju djece u dobi od 6 i više godina kojima je tjelesna težina manja od 20 kg.
English: Zonisamide Mylan 25 mg hard capsules Zonisamide Mylan 50 mg hard capsules Zonisamide Mylan 100 mg hard capsules zonisamide
Croatian: Zonisamide Mylan 25 mg tvrde kapsule Zonisamide Mylan 50 mg tvrde kapsule Zonisamide Mylan 100 mg tvrde kapsule zonisamid
English: Musculoskeletal and connective tissue disorders
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva rabdomioliza
English: Patients of weight 20 to 55 kga
Croatian: 1. tjedan 2. do 8. tjedan Bolesnici težine 20 do 55 kg a
English: - The recommended daily dose is between 300 mg and 500 mg. - Some people respond to lower doses.
Croatian: - Preporučena je dnevna doza između 300 mg i 500 mg.
English: Nephrolithiasis Calculus urinary Hydronephrosis Renal failure
Croatian: Poremećaji bubrega i mokraćnog sustava nefrolitijaza urinarni kalkulus hidronefroza, zatajenje bubrega, nenormalna mokraća
English: 300 mg per day (once a day).
Croatian: 300 mg na dan (jedanput na dan)
English: ≥ 1/10,000 to < 1/1,000
Croatian: ≥ 1/10 000 i < 1/1000 vrlo rijetko < 1/10 000 nepoznato ne može se procijeniti iz dostupnih podataka
English: Zonisamide Mylan 25 mg hard capsules Zonisamide Mylan 50 mg hard capsules Zonisamide Mylan 100 mg hard capsules
Croatian: Zonisamide Mylan 25 mg tvrde kapsule Zonisamide Mylan 50 mg tvrde kapsule Zonisamide Mylan 100 mg tvrde kapsule
English: Read the package leaflet before use Oral use
Croatian: Prije uporabe pročitajte uputu o lijeku.
English: 200 mg/day (once a day)
Croatian: 200 mg na dan (jedanput na dan)
English: A white opaque body and a white opaque cap, marked ‘Z 100' in black containing white/almost white powder.
Croatian: Bijelo neprozirno tijelo i bijela neprozirna kapica s crnom oznakom „Z 100” sadrže bijeli/gotovo bijeli prašak.
English: A white opaque body and a white opaque cap, marked ‘Z 50' in red containing white/almost white powder.
Croatian: Bijelo neprozirno tijelo i bijela neprozirna kapica s crvenom oznakom „Z 50” sadrže bijeli/gotovo bijeli prašak.
English: Be especially careful while driving or operating machinery if Zonisamide Mylan affects you in this way.
Croatian: Ako Zonisamide Mylan na Vas tako djeluje budite posebno pažljivi kada upravljate vozilima ili rukujete strojevima.
English: CYP3A4-inducing agents
Croatian: - bez lijekova induktora CYP3A4
English: You must only take Zonisamide Mylan during your pregnancy if your doctor tells you to. Research has shown an increased risk of birth defects in children of women taking anti-epileptic medicines.
Croatian: Za vrijeme trudnoće Zonisamide Mylan smijete uzeti samo ako Vam je to rekao liječnik.
English: 117 Allee des Parcs 69 800 Saint Priest France
Croatian: 69 800 Saint Priest
English: A white opaque body and a white opaque cap, marked ‘Z 25' in black containing white/almost white powder.
Croatian: Bijelo neprozirno tijelo i bijela neprozirna kapica s crnom oznakom „Z 25” sadrže bijeli/gotovo bijeli prašak.
English: Talk to your doctor or pharmacist before taking Zonisamide Mylan if you:
Croatian: Nemojte uzimati Zonisamide Mylan ako ste:
English: Urinary tract infection Pneumonia
Croatian: Infekcije i infestacije infekcija mokraćnog sustava, pneumonija
English: Zonisamide Mylan 25 mg hard capsules zonisamide
Croatian: Zonisamide Mylan 25 mg tvrde kapsule zonisamid
English: Zonisamide Mylan 100 mg hard capsules zonisamide
Croatian: Zonisamide Mylan 100 mg tvrde kapsule zonisamid
English: Abdominal pain Constipation Diarrhoea Dyspepsia Nausea
Croatian: Poremećaji probavnog sustava bol u trbuhu, konstipacija, proljev, dispepsija, mučnina povraćanje pankreatitis
English: Each capsule contains 100 mg of zonisamide.
Croatian: Jedna kapsula sadrži 100 mg zonisamida.
English: Each hard capsule contains 100 mg zonisamide.
Croatian: Jedna tvrda kapsula sadrži 100 mg zonisamida.
English: Cholecystitis acute
Croatian: Bubrežni kamenci
English: Confusional state Acute psychosis Aggression Suicidal ideation Hallucination
Croatian: Psihijatrijski poremećaji agitacija, depresija, nesanica, promjene raspoloženja, anksioznost stanje konfuzije, akutna psihoza, agresija, suicidalna ideacija, halucinacije
English: Withdrawal
Croatian: Ukidanje
English: Zonisamide Mylan 100 mg hard capsules
Croatian: Zonisamide Mylan 100 mg tvrde kapsule
English: Each hard capsule contains 25 mg zonisamide.
Croatian: Jedna tvrda kapsula sadrži 25 mg zonisamida.
English: Each capsule contains 25 mg of zonisamide.
Croatian: Jedna kapsula sadrži 25 mg zonisamida.
English: Zonisamide Mylan 50 mg hard capsules zonisamide
Croatian: Zonisamide Mylan 50 mg tvrde kapsule zonisamid
English: Agranulocytosis Aplastic anaemia Leucocytosis Leucopoenia Lymphadenopathy Pancytopenia, Thrombocytopenia
Croatian: Poremećaji krvi i limfnog sustava ekhimoza agranulocitoza, aplastična anemija, leukocitoza, leukopenija, limfadenopatija, pancitopenija, trombocitopenija
English: Zonisamide Mylan 25 mg hard capsules
Croatian: Zonisamide Mylan 25 mg tvrde kapsule
English: Each hard capsule contains 50 mg zonisamide.
Croatian: Jedna tvrda kapsula sadrži 50 mg zonisamida.
English: Pneumonia Urinary tract infection
Croatian: Infekcije i infestacije pneumonija, infekcija, mokraćnog sustava
English: Each capsule contains 50 mg of zonisamide.
Croatian: Jedna kapsula sadrži 50 mg zonisamida.
English: Cognition
Croatian: Kognitivne sposobnosti
English: Metabolism and nutrition disorders
Croatian: Poremećaji metabolizma i prehrane oslabljen apetit hipokalemija
English: Zonisamide Mylan 50 mg hard capsules
Croatian: Zonisamide Mylan 50 mg tvrde kapsule